Mechanisms with network pharmacology approach of Ginsenosides in Alzheimer's disease

Shan He(Wangjing Hospital of China Academy of Chinese Medical Sciences), Hao Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Ping Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Hui Pei(Jinan Central Hospital), Lina Ma(Chinese Academy of Medical Sciences & Peking Union Medical College), Dazhuo Shi(Xiyuan Hospital), Junhe Shi(Chinese Academy of Medical Sciences & Peking Union Medical College), Hua Chai(Sichuan University)
Heliyon
February 19, 2024
10.1016/j.heliyon.2024.e26642
Cited by 14

Related Papers

Combination of Hua Shi Bai Du granule (Q-14) and standard care in the treatment of patients with coronavirus disease 2019 (COVID-19): A single-center, open-label, randomized controlled trial
|Phytomedicine|2021|71
Efficacy and safety of Chinese herbal medicine versus Lopinavir-Ritonavir in adult patients with coronavirus disease 2019: A non-randomized controlled trial
|Phytomedicine|2020|59
G Protein-Coupled Estrogen Receptor 1 Inhibits Angiotensin II-Induced Cardiomyocyte Hypertrophy via the Regulation of PI3K-Akt-mTOR Signalling and Autophagy
|International Journal of Biological Sciences|2018|55
Ginkgolide B Reduces LOX-1 Expression by Inhibiting Akt Phosphorylation and Increasing Sirt1 Expression in Oxidized LDL-Stimulated Human Umbilical Vein Endothelial Cells
|PLoS ONE|2013|44
Paeonol Protects Rat Heart by Improving Regional Blood Perfusion during No-Reflow
|Frontiers in Physiology|2016|33